Cencora Return on Investment 2012-2026 | COR
Current and historical return on investment (ROI) values for Cencora (COR) over the last 10 years.
| Cencora ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2026-03-31 | $2.79B | $11.25B | 24.80% |
| 2025-12-31 | $2.68B | $9.37B | 28.62% |
| 2025-09-30 | $2.63B | $8.53B | 30.82% |
| 2025-06-30 | $2.74B | $7.35B | 37.22% |
| 2025-03-31 | $2.54B | $6.10B | 41.68% |
| 2024-12-31 | $2.06B | $5.38B | 38.24% |
| 2024-09-30 | $2.18B | $5.12B | 42.48% |
| 2024-06-30 | $2.53B | $5.17B | 48.81% |
| 2024-03-31 | $2.52B | $5.14B | 49.11% |
| 2023-12-31 | $2.53B | $5.08B | 49.83% |
| 2023-09-30 | $2.34B | $4.95B | 47.29% |
| 2023-06-30 | $2.32B | $4.92B | 47.10% |
| 2023-03-31 | $2.14B | $4.94B | 43.22% |
| 2022-12-31 | $2.36B | $5.04B | 46.76% |
| 2022-09-30 | $2.37B | $5.61B | 42.20% |
| 2022-06-30 | $2.47B | $6.17B | 40.06% |
| 2022-03-31 | $2.61B | $6.65B | 39.22% |
| 2021-12-31 | $2.45B | $6.77B | 36.20% |
| 2021-09-30 | $2.35B | $5.80B | 40.59% |
| 2021-06-30 | $-4.32B | $4.75B | -90.93% |
| 2021-03-31 | $-4.54B | $4.89B | -92.87% |
| 2020-12-31 | $-4.85B | $5.21B | -93.18% |
| 2020-09-30 | $-5.14B | $6.10B | -84.18% |
| 2020-06-30 | $1.16B | $7.24B | 15.99% |
| 2020-03-31 | $1.16B | $7.21B | 16.10% |
| 2019-12-31 | $0.90B | $7.23B | 12.43% |
| 2019-09-30 | $1.11B | $7.47B | 14.90% |
| 2019-06-30 | $1.09B | $7.52B | 14.45% |
| 2019-03-31 | $1.07B | $7.62B | 14.03% |
| 2018-12-31 | $1.50B | $7.77B | 19.32% |
| 2018-09-30 | $1.44B | $7.73B | 18.68% |
| 2018-06-30 | $1.15B | $7.30B | 15.81% |
| 2018-03-31 | $0.94B | $6.92B | 13.51% |
| 2017-12-31 | $1.08B | $6.51B | 16.57% |
| 2017-09-30 | $1.06B | $6.14B | 17.28% |
| 2017-06-30 | $1.42B | $6.17B | 23.02% |
| 2017-03-31 | $1.78B | $6.00B | 29.64% |
| 2016-12-31 | $2.10B | $6.05B | 34.77% |
| 2016-09-30 | $1.53B | $5.98B | 25.53% |
| 2016-06-30 | $1.84B | $5.57B | 33.09% |
| 2016-03-31 | $1.65B | $5.48B | 30.05% |
| 2015-12-31 | $0.33B | $5.31B | 6.28% |
| 2015-09-30 | $0.42B | $4.82B | 8.77% |
| 2015-06-30 | $0.09B | $4.72B | 1.93% |
| 2015-03-31 | $-0.13B | $4.39B | -2.98% |
| 2014-12-31 | $0.53B | $3.81B | 14.01% |
| 2014-09-30 | $0.78B | $3.78B | 20.69% |
| 2014-06-30 | $0.69B | $3.72B | 18.43% |
| 2014-03-31 | $0.71B | $3.68B | 19.30% |
| 2013-12-31 | $0.76B | $3.73B | 20.35% |
| 2013-09-30 | $0.90B | $3.75B | 23.94% |
| 2013-06-30 | $1.11B | $3.79B | 29.19% |
| 2013-03-31 | $1.29B | $3.94B | 32.88% |
| 2012-12-31 | $1.32B | $4.11B | 32.15% |
| 2012-09-30 | $1.30B | $4.27B | 30.50% |
| 2012-06-30 | $1.21B | $4.27B | 28.39% |
| 2012-03-31 | $1.21B | $4.31B | 27.98% |
| 2011-12-31 | $1.19B | $4.32B | 27.63% |
| 2011-09-30 | $1.19B | $4.28B | 27.76% |
| 2011-06-30 | $1.20B | $4.40B | 27.18% |
| 2011-03-31 | $1.16B | $4.33B | 26.80% |
| 2010-12-31 | $1.11B | $4.26B | 25.98% |
| 2010-09-30 | $1.09B | $4.22B | 25.83% |
| 2010-06-30 | $1.08B | $4.12B | 26.20% |
| 2010-03-31 | $1.01B | $4.04B | 25.00% |
| 2009-12-31 | $0.95B | $3.98B | 23.85% |
| 2009-09-30 | $0.88B | $3.92B | 22.54% |
| 2009-06-30 | $0.86B | $3.92B | 21.97% |
| 2009-03-31 | $0.85B | $3.92B | 21.62% |
| 2008-12-31 | $0.83B | $3.98B | 20.95% |
| 2008-09-30 | $0.83B | $4.04B | 20.52% |
| 2008-06-30 | $0.78B | $4.15B | 18.86% |
| 2008-03-31 | $0.79B | $4.40B | 17.90% |
| 2007-12-31 | $0.77B | $4.68B | 16.53% |
| 2007-09-30 | $0.79B | $4.93B | 16.00% |
| 2007-06-30 | $0.77B | $5.16B | 14.99% |
| 2007-03-31 | $0.76B | $5.25B | 14.46% |
| 2006-12-31 | $0.74B | $5.31B | 13.86% |
| 2006-09-30 | $0.69B | $5.37B | 12.93% |
| 2006-06-30 | $0.71B | $5.37B | 13.22% |
| 2006-03-31 | $0.69B | $5.30B | 13.01% |
| 2005-12-31 | $0.67B | $5.17B | 12.97% |
| 2005-09-30 | $0.64B | $5.16B | 12.35% |
| 2005-06-30 | $0.66B | $5.22B | 12.64% |
| 2005-03-31 | $0.74B | $5.41B | 13.74% |
| 2004-12-31 | $0.82B | $5.57B | 14.78% |
| 2004-09-30 | $0.90B | $5.69B | 15.82% |
| 2004-06-30 | $0.96B | $5.75B | 16.64% |
| 2004-03-31 | $0.93B | $5.84B | 15.97% |
| 2003-12-31 | $0.91B | $5.84B | 15.57% |
| 2003-09-30 | $0.89B | $5.74B | 15.45% |
| 2003-06-30 | $0.85B | $5.58B | 15.19% |
| 2003-03-31 | $0.80B | $5.22B | 15.38% |
| 2002-12-31 | $0.76B | $4.93B | 15.33% |
| 2002-09-30 | $0.72B | $4.80B | 14.97% |
| 2002-06-30 | $0.63B | $4.71B | 13.29% |
| 2002-03-31 | $0.50B | $3.80B | 13.23% |
| 2001-12-31 | $0.38B | $2.87B | 13.10% |
| 2001-09-30 | $0.28B | $1.90B | 14.67% |
| 2001-06-30 | $0.23B | $0.90B | 26.04% |
| 2001-03-31 | $0.22B | $0.83B | 26.67% |
| 2000-12-31 | $0.21B | $0.79B | 26.35% |
| 2000-09-30 | $0.20B | $0.77B | 26.21% |
| 2000-06-30 | $-0.42B | $0.77B | -54.39% |
| 2000-03-31 | $-0.43B | $0.76B | -56.62% |
| 1999-12-31 | $-0.44B | $0.75B | -58.59% |
| 1999-09-30 | $-0.45B | $0.71B | -63.43% |
| 1999-06-30 | $0.28B | $0.66B | 42.91% |
| 1999-03-31 | $0.28B | $0.63B | 44.46% |
| 1998-12-31 | $0.28B | $0.64B | 43.35% |
| 1998-09-30 | $0.28B | $0.66B | 41.99% |
| 1998-06-30 | $0.15B | $0.68B | 22.04% |
| 1998-03-31 | $0.13B | $0.66B | 20.31% |
| 1997-12-31 | $0.13B | $0.65B | 19.66% |
| 1997-09-30 | $0.12B | $0.59B | 20.34% |
| 1997-06-30 | $0.10B | $0.54B | 18.95% |
| 1997-03-31 | $0.11B | $0.51B | 21.14% |
| 1996-12-31 | $0.10B | $0.45B | 22.78% |
| 1996-09-30 | $0.10B | $0.40B | 24.42% |
| 1996-06-30 | $0.19B | $0.37B | 50.94% |
| 1996-03-31 | $0.19B | $0.34B | 55.70% |
| 1995-12-31 | $-1.02B | $0.32B | -315.79% |
| 1995-09-30 | $-1.02B | $0.26B | -386.75% |
| 1995-06-30 | $-0.05B | $0.23B | -21.96% |
| 1995-03-31 | $1.00B | $0.17B | 607.56% |
| 1994-12-31 | $3.25B | $0.08B | 4038.51% |
| 1994-09-30 | $4.28B | $0.04B | 9941.86% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $62.409B | $321.333B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.187B | 24.31 |
| HCA Healthcare (HCA) | United States | $110.772B | 17.53 |
| CVS Health (CVS) | United States | $101.670B | 11.75 |
| Elevance Health (ELV) | United States | $68.432B | 10.33 |
| Natera (NTRA) | United States | $27.358B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.501B | 15.87 |
| DiDi Global (DIDIY) | China | $18.026B | 15.96 |
| Viatris (VTRS) | United States | $15.685B | 5.71 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.535B | 0.00 |
| Medpace Holdings (MEDP) | United States | $14.094B | 32.26 |
| BioMerieux (BMXMF) | France | $12.476B | 0.00 |
| Solventum (SOLV) | United States | $11.408B | 10.78 |
| Revvity (RVTY) | United States | $10.039B | 17.71 |
| BrightSpring Health Services (BTSG) | United States | $8.774B | 43.59 |
| Charles River Laboratories (CRL) | United States | $8.667B | 17.09 |
| ICON (ICLR) | Ireland | $8.626B | 8.56 |
| CochLear (CHEOY) | Australia | $8.030B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.905B | 0.00 |
| HealthEquity (HQY) | United States | $6.586B | 23.20 |
| Bausch + Lomb (BLCO) | Canada | $5.877B | 32.98 |
| GETINGE (GNGBY) | Sweden | $5.626B | 17.96 |
| Avantor (AVTR) | United States | $5.388B | 8.68 |
| PACS (PACS) | United States | $5.304B | 27.44 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.101B | 0.00 |
| Sotera Health (SHC) | United States | $4.380B | 19.95 |
| Alignment Healthcare (ALHC) | United States | $4.188B | 0.00 |
| Concentras Parent (CON) | United States | $2.818B | 16.12 |
| Organon (OGN) | United States | $2.299B | 2.57 |
| Amplifon S.p.A (AMFPF) | Italy | $2.275B | 13.27 |
| Pediatrix Medical (MD) | United States | $1.782B | 11.11 |
| Establishment Labs Holdings (ESTA) | United States | $1.765B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.746B | 42.28 |
| Surgery Partners (SGRY) | United States | $1.671B | 41.65 |
| Sonida Senior Living (SNDA) | United States | $1.544B | 0.00 |
| Ardent Health (ARDT) | United States | $1.345B | 5.70 |
| Progyny (PGNY) | United States | $1.277B | 25.08 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.240B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.113B | 164.00 |
| Teladoc Health (TDOC) | United States | $0.920B | 0.00 |
| CareDx (CDNA) | United States | $0.822B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.750B | 12.17 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Nutex Health (NUTX) | United States | $0.704B | 11.25 |
| Omada Health (OMDA) | United States | $0.672B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.604B | 99.85 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.531B | 0.00 |
| Embecta (EMBC) | United States | $0.524B | 2.92 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.435B | 4.70 |
| SBC Medicals (SBC) | United States | $0.426B | 8.47 |
| Forward Industries (FWDI) | United States | $0.375B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.349B | 0.00 |
| Agilon Health (AGL) | United States | $0.316B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| So-Young (SY) | China | $0.262B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Biodesix (BDSX) | United States | $0.133B | 0.00 |
| Beauty Health (SKIN) | United States | $0.115B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.080B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.077B | 0.00 |
| DocGo (DCGO) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.015B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.005B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |